In focus
Latest feed
Teva's Strategic Pivot Gains Traction: Innovative Growth Offsets Generics Slide in Q2 2026
A $10 Billion Shake-Up: Vertex Pharmaceuticals to Acquire Crinetics in Major Cash Deal
A Bipartisan Push? Republican Lawmakers Tackle Clinical Trial Diversity
The Capitol's Pulse: When Wellness Met Wealth, and Big Pharma Prevailed